Nathalie Guillen

Sphingosine‐1‐phosphate (S1P) induces potent anti‐inflammatory effects <i>in vitro</i> and <i>in vivo</i> by S1P receptor 4‐mediated suppression of 5‐lipoxygenase activity

Jasmin Fettel, Benjamin Kühn, Nathalie Guillen et al. · The FASEB Journal · 2018 · 41 citations

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML

Claudia Oancea, Brigitte Rüster, Boris Brill et al. · Genes & Cancer · 2014 · 16 citations · Full text

Oral administration of the selective <scp>GPR</scp>120/<scp>FFA</scp>4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases

Melanie Wannick, Siegfried Bezdek, Nathalie Guillen et al. · Pharmacology Research & Perspectives · 2018 · 16 citations · Full text